Darryl Sampey
Director, President and CEO
Biotechnology
BioFactura Inc
United States of America
Biography
Darryl Sampey co-founded BioFactura in 2004 and as President and CEO manages all strategic and scientific endeavors of the Company. Before BioFactura, he led both process development and manufacturing teams at Human Genome Sciences, Inc. (HGS) honing his skills developing new biologics processes and control strategies. During his tenure with HGS, Dr. Sampey played key roles in the start-up, commissioning, and validation of the company’s first cGMP manufacturing facility and associated development laboratories. Additionally, he performed lead roles in the development, transfer, and evaluation of novel fermentation processes for cGMP clinical manufacturing. Prior to his work at HGS, Dr. Sampey gained industrial experience in the commercial research laboratory designing and optimizing fermentation and product recovery processes for novel vaccines at North American Vaccine, Inc. His work in vaccine research has since progressed to internationally-approved vaccines for whooping cough in infants and meningitis in adults. Darryl Sampey began his career in biotechnology at the University of Maryland. Dr. Sampey graduated first in his class and was awarded a Bachelor of Science in Chemical Engineering, Magna Cum Laude, and subsequently earned a Ph.D. in Bioengineering both from the University of Maryland.
Research Interest
His work in vaccine research has since progressed to internationally-approved vaccines for whooping cough in infants and meningitis in adults